• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Psychiatric care of patients with depression and comorbid substance use disorders.患有抑郁症和共病物质使用障碍患者的精神科护理。
J Clin Psychiatry. 2000 Sep;61(9):698-705; quiz 706. doi: 10.4088/jcp.v61n0917.
2
The effects of substance use disorder on the clinical presentation of anxiety and depression in an outpatient psychiatric clinic.物质使用障碍对门诊精神科诊所中焦虑和抑郁临床表现的影响。
J Clin Psychiatry. 1995 Dec;56(12):549-55.
3
Depression care among depressed adults with and without comorbid substance use disorders in the United States.美国患有和未患有合并物质使用障碍的抑郁症成年人的抑郁症护理情况。
Depress Anxiety. 2017 Mar;34(3):291-300. doi: 10.1002/da.22592. Epub 2017 Feb 2.
4
Comparison of the course of substance use disorders among individuals with and without generalized anxiety disorder in a nationally representative sample.在全国代表性样本中,比较有和没有广泛性焦虑障碍的个体的物质使用障碍病程。
J Psychiatr Res. 2012 May;46(5):659-66. doi: 10.1016/j.jpsychires.2012.02.011. Epub 2012 Mar 23.
5
Comorbid mental disorders in substance users from a single catchment area--a clinical study.物质使用者共病精神障碍的单流域临床研究。
BMC Psychiatry. 2011 Feb 12;11:25. doi: 10.1186/1471-244X-11-25.
6
Treatment compliance in patients with comorbid psychiatric and substance use disorders.患有共病性精神障碍和物质使用障碍患者的治疗依从性。
Am J Addict. 2005 May-Jun;14(3):195-207. doi: 10.1080/10550490590949488.
7
The associations between substance use disorders, schizophrenia-spectrum disorders, and Axis IV psychosocial problems.物质使用障碍、精神分裂症谱系障碍与轴IV心理社会问题之间的关联。
Soc Psychiatry Psychiatr Epidemiol. 2005 Dec;40(12):939-46. doi: 10.1007/s00127-005-0964-4. Epub 2005 Oct 25.
8
Differences among major depressive disorder with and without co-occurring substance use disorders and substance-induced depressive disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions.主要抑郁障碍伴或不伴物质使用障碍及物质所致抑郁障碍的差异:来自国家酒精相关条件流行病学调查的结果。
J Clin Psychiatry. 2012 Jun;73(6):865-73. doi: 10.4088/JCP.10m06673. Epub 2012 Mar 20.
9
Roles and practices of general practitioners and psychiatrists in management of depression in the community.全科医生和精神科医生在社区抑郁症管理中的角色与实践。
BMC Fam Pract. 2006 Jan 30;7:5. doi: 10.1186/1471-2296-7-5.
10
Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study.患有和未患有注意力缺陷多动障碍的寻求治疗的物质使用障碍患者的精神共病:IASP研究结果
Addiction. 2014 Feb;109(2):262-72. doi: 10.1111/add.12370. Epub 2013 Nov 20.

引用本文的文献

1
Resilience and relapse risk in Emirate adult patients with substance use disorder: a national cross-sectional study from the United Arab Emirates.阿联酋成年物质使用障碍患者的恢复力和复发风险:一项来自阿拉伯联合酋长国的全国性横断面研究。
Front Psychiatry. 2024 Sep 24;15:1444233. doi: 10.3389/fpsyt.2024.1444233. eCollection 2024.
2
Revisiting practice-based research networks as a platform for mental health services research.重新审视基于实践的研究网络作为心理健康服务研究的平台。
Adm Policy Ment Health. 2009 Sep;36(5):308-21. doi: 10.1007/s10488-009-0222-2. Epub 2009 Apr 28.
3
Identification and treatment of patients with nicotine problems in routine clinical psychiatry practice.在常规临床精神病学实践中识别和治疗有尼古丁问题的患者。
Am J Addict. 2005 Oct-Dec;14(5):441-54. doi: 10.1080/10550490500247123.
4
Influence of psychotherapy attendance on buprenorphine treatment outcome.心理治疗参与度对丁丙诺啡治疗效果的影响。
J Subst Abuse Treat. 2005 Apr;28(3):247-54. doi: 10.1016/j.jsat.2005.01.004.
5
Demographic and practice characteristics of psychiatrists who primarily treat patients with substance use disorders.主要治疗物质使用障碍患者的精神科医生的人口统计学和执业特征。
Am J Addict. 2003 May-Jun;12(3):181-92. doi: 10.1080/10550490390201759.
6
Heroin detoxification with buprenorphine on an inpatient psychiatric unit.在精神科住院部使用丁丙诺啡进行海洛因脱毒治疗。
J Subst Abuse Treat. 2002 Oct;23(3):163-9. doi: 10.1016/s0740-5472(02)00244-1.

本文引用的文献

1
Psychiatric patients and treatments in 1997: findings from the American Psychiatric Practice Research Network.1997年的精神病患者与治疗:美国精神病学实践研究网络的研究结果
Arch Gen Psychiatry. 1999 May;56(5):441-9. doi: 10.1001/archpsyc.56.5.441.
2
Substance abuse history predicts depression and relapse status among cocaine abusers.药物滥用史可预测可卡因滥用者的抑郁和复发状况。
Am J Addict. 1999 Winter;8(1):1-8. doi: 10.1080/105504999306027.
3
Comorbidity of substance use disorders with mood and anxiety disorders: results of the International Consortium in Psychiatric Epidemiology.物质使用障碍与心境障碍和焦虑障碍的共病情况:国际精神疾病流行病学联盟的研究结果
Addict Behav. 1998 Nov-Dec;23(6):893-907. doi: 10.1016/s0306-4603(98)00076-8.
4
The comorbidity of alcoholism with anxiety and depressive disorders in four geographic communities.四个地理社区中酒精中毒与焦虑症和抑郁症的共病情况。
Compr Psychiatry. 1998 Jul-Aug;39(4):176-84. doi: 10.1016/s0010-440x(98)90058-x.
5
Substance use disorders among inpatients with bipolar disorder and major depressive disorder in a general hospital.综合医院双相情感障碍和重度抑郁症住院患者的物质使用障碍
Gen Hosp Psychiatry. 1998 Mar;20(2):98-101. doi: 10.1016/s0163-8343(98)00003-6.
6
Fluoxetine versus placebo in depressed alcoholic cocaine abusers.氟西汀与安慰剂治疗酒精性可卡因成瘾伴抑郁症患者的对照研究
Psychopharmacol Bull. 1998;34(1):117-21.
7
Sociodemographic representation in published studies of cocaine abuse pharmacotherapy.可卡因滥用药物治疗已发表研究中的社会人口学代表性。
Drug Alcohol Depend. 1998 Jan 1;49(2):89-93. doi: 10.1016/s0376-8716(97)00143-9.
8
Psychiatric hospital outcomes of dual diagnosis patients under managed care.管理式医疗下双重诊断患者的精神病院治疗结果。
Am J Addict. 1998 Winter;7(1):81-6.
9
Characterizing psychiatry with findings from the 1996 National Survey of Psychiatric Practice.用1996年全国精神病学实践调查结果描述精神病学特征。
Am J Psychiatry. 1998 Mar;155(3):397-404. doi: 10.1176/ajp.155.3.397.
10
Imipramine treatment of opiate-dependent patients with depressive disorders. A placebo-controlled trial.丙咪嗪治疗伴有抑郁症的阿片类药物依赖患者:一项安慰剂对照试验。
Arch Gen Psychiatry. 1998 Feb;55(2):153-60. doi: 10.1001/archpsyc.55.2.153.

患有抑郁症和共病物质使用障碍患者的精神科护理。

Psychiatric care of patients with depression and comorbid substance use disorders.

作者信息

Montoya I D, Svikis D, Marcus S C, Suarez A, Tanielian T, Pincus H A

机构信息

Practice Research Network of the American Psychiatric Institute for Research and Education, Washington, DC 20005, USA.

出版信息

J Clin Psychiatry. 2000 Sep;61(9):698-705; quiz 706. doi: 10.4088/jcp.v61n0917.

DOI:10.4088/jcp.v61n0917
PMID:11030495
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10902911/
Abstract

BACKGROUND

The goal of this study was to describe the sociodemographic and clinical characteristics and routine psychiatric care of depressed patients with or without substance use disorders (SUDs) and to assess the association between the presence of comorbid SUD and the psychiatric management of patients with depression.

METHOD

Each of a sample of 531 psychiatrists participating in the Practice Research Network (PRN) of the American Psychiatric Institute for Research and Education was asked to provide information about 3 randomly chosen patients. Data were collected using a self-administered questionnaire, which generated detailed diagnostic and clinical data on 1228 psychiatric patients. Weighted data were analyzed using the SUDAAN software package. Multivariate logistic regression was used to compare depressed patients with and without SUD.

RESULTS

A total of 595 patients (48.4%) were diagnosed with depression (DSM-IV criteria). The prevalence of SUD (excluding nicotine dependence) in this group was 18.1%. The group with SUD had a significantly larger proportion of males, young adults, patients seen in public general hospitals, and non-managed care public plans. No significant group differences were found for primary payer, locus of care, length of treatment, type of current or past treatment, and prescription of medications. Only 2.2% of SUD patients were prescribed with an anti-SUD medication (i.e., disulfiram and naltrexone).

CONCLUSION

Concomitant SUDs have little effect on the routine psychiatric care of depressed patients. Efforts should be made to improve the identification and management of depressed patients with SUD.

摘要

背景

本研究的目的是描述伴有或不伴有物质使用障碍(SUDs)的抑郁症患者的社会人口学和临床特征以及常规精神科护理情况,并评估共病SUD的存在与抑郁症患者精神科治疗之间的关联。

方法

参与美国精神医学研究与教育学会实践研究网络(PRN)的531名精神科医生样本中的每一位,均被要求提供3名随机选择患者的信息。使用一份自行填写的问卷收集数据,该问卷生成了1228名精神科患者的详细诊断和临床数据。使用SUDAAN软件包对加权数据进行分析。采用多变量逻辑回归比较伴有和不伴有SUD的抑郁症患者。

结果

共有595名患者(48.4%)被诊断为抑郁症(依据《精神疾病诊断与统计手册》第四版标准)。该组中SUD(不包括尼古丁依赖)的患病率为18.1%。患有SUD的组中男性、年轻人、在公立综合医院就诊的患者以及非管理式医疗公共计划的患者比例显著更高。在主要支付方、护理地点、治疗时长、当前或过去的治疗类型以及药物处方方面,未发现显著的组间差异。只有2.2%的SUD患者被开具了抗SUD药物(即双硫仑和纳曲酮)。

结论

共病SUD对抑郁症患者的常规精神科护理影响不大。应努力改善对伴有SUD的抑郁症患者的识别和管理。